To evaluate the effectiveness of enhanced behavioural intervention and use of technology (Continuous glucose monitoring) for improving pregnancy outcomes in women with type 2 Diabetes mellitus: A three-arm parallel Randomised Controlled Trialâ??

Department of Endocrinology and Metabolism0 个研究点目标入组 0 人开始时间: 待定最近更新: 2023年6月26日

试验速览

暂无简介。

•1.Pregnant women with type 2 Diabetes Mellitus (period of gestation <15 weeks)
•2.Pregnant women with overt diabetes but diagnosed before 12 weeks of pregnancy. As per ADA guidelines, these women usually have pre-existing type 2 diabetes.
•3.Live singleton fetus (US done to confirm gestational age, viability and rule out multiple pregnancy)
•4.Age >= 18 years and less than 50 years
•5.Enrolled either in Department of Endocrinology and Metabolism or Obstetrics and Gynecology, All India Institute of Medical Sciences, New Delhi.
•6.Willing to comply with study protocol

•1.Type 1 diabetes mellitus, secondary diabetes gestational diabetes mellitus
•2.Have used CGMS in the previous 3 months
•3.Inflammatory or connective tissue disorders requiring or required use of immunosuppressive or steroids or disease-modifying agents in the past â?¡ 4.Chronic organ diseases affecting heart, lung, kidney, liver, brain.
•5.HBsAg, Anti-HCV or HIV positive
•6.Active infection
•7.Diseases/conditions or drugs that may result in hyperglycemia as per ADA classification will also be excluded.
•8.Psychiatric or any other issues, which may interfere with the study compliance, as judged by the investigators.

发起方

Department of Endocrinology and Metabolism